Neurodegenerative Disease

LEXINGTON, Mass. and AMSTERDAM September 29, 2026 — uniQure N.V. announced additional data from ongoing Phase 1/2 studies of...

BOSTON — September 28, 2026 CervoMed Inc. announced pharmacokinetic, regulatory and manufacturing advances for neflamapimod, including a new 50...

DEER PARK, Ill. — September 28, 2026 Eton Pharmaceuticals, Inc. announced the U.S. commercial launch of IMPAVIDO® (miltefosine) capsules,...

BOSTON, Mass. — September 28, 2026 Tiziana Life Sciences, Ltd. announced that the first three participants have been dosed...

LAUSANNE, Switzerland — September 23, 2026 AC Immune SA reported positive safety and immunogenicity results through Week 100 from...

Carlsbad, California, U.S., September 22, 2026 Ionis Pharmaceuticals, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. have announced positive...

BOSTON, Mass. — September 21, 2026 Tiziana Life Sciences announced that the last patient has completed the last visit...

CLEVELAND, Ohio — September 18, 2026 Abeona Therapeutics congratulated Ultragenyx Pharmaceutical on the U.S. FDA approval of FAYUVI™ (rebisufligene...

Novato, California, U.S., September 17, 2026 Ultragenyx Pharmaceutical Inc. announced that the U.S. Food and Drug Administration (FDA) has...

Yongin, South Korea, September 17, 2026 1ST Biotherapeutics, Inc. (1STBIO) and SK Biopharmaceuticals Co., Ltd. (SKBP) have announced an...